SEARCH   
MEMBER LOGIN    

Intravenous (IV) Solution Manufacturing in the US: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Intravenous (IV) Solution Manufacturing Market Research Report | Life Sciences | Medical Supplies | Aug 2014

Free flowing: The consistent need for IV solutions has kept industry growth steady

The Intravenous (IV) Solution Manufacturing market research report provides key industry analysis and industry statistics, measures market size, analyzes current and future industry trends and shows market share for the industry’s largest companies. IBISWorld publishes the largest collection of industry reports so you can see an industry’s supply chain, economic drivers and key buyers and markets.

Report Snapshot
Market Share of Companies
Baxter International Inc. Baxter International Inc. market share
Hospira Inc. Hospira Inc. market share
Industry Statistics & Market Size
Revenue
$4bn
Annual Growth 09-14
7.0%
Annual Growth 14-19
Purchase to read more
Profit
Purchase to read more
Employment
6,060
Businesses
35
Industry Analysis & Industry Trends

Whether for delivering anesthesia or nutrients, the Intravenous (IV) Solution Manufacturing industry provides hospitals with an array of IV solutions. Since the industry relies mainly on downstream demand from hospitals, the number of people with health insurance plays a critical role in determining demand for IV solutions. Forthcoming changes to the nation's healthcare system under the Patient Protection and Affordable Care Act of 2010 are anticipated to increase the number of insured Americans over the next five years. In turn, hospital demand is projected to rise and help support demand for IV solutions.... purchase to read more

Industry Report - Industry Investment Chapter

The Intravenous Solution Manufacturing industry exhibits a moderate level of capital intensity. Using depreciation as a proxy for capital expenditures and wage as a measure of labor costs, IBISWorld estimates that for every $1.00 spent on labor, industry manufacturers spend $0.25 on capital in 2014. This marks an increase from $0.22 in 2009. Wages have typically accounted for 10-15% of revenue, a figure that accounts for the specialized nature of labor in the industry. It is also a figure that has declined to 9.8% in 2014. As wages' portion of revenue continues to fall, depreciation and consequently capital investments continues to remain constant, hovering around 2.4%... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Intravenous (IV) Solution Manufacturing Industry?

Companies in this industry primarily engage in manufacturing substances that may be infused directly into a vein using a venous access device. Intravenous (IV) solutions may be used to correct electrolyte imbalances, to deliver medications, for blood transfusion or as fluid replacement. Solutions specifically for animals are excluded from this industry.

Industry Products
CrystalloidsColloidsBlood productsOxygen-carrying solutions
 
Industry Activities
Manufacturing crystalloid solutionsManufacturing colloid solutionsManufacturing blood productsManufacturing oxygen-carrying products


View Sample
Quote
Select Clients